The Chinese Familial Alzheimer’s Network
Learn more about:
Related Clinical Trial
Gut Microbiome and Blood Indices in Patients With AD and Their Spousal Caregivers
China Longitudinal Aging and Cognitive Impairment Study
Study of Safety, Tolerability, Pharmacodynamics and Pharmacokinetics of NIO752 in Early Alzheimer’s Disease Participants
Multi-Center Development of a Novel Diagnostic Test for Alzheimer’s Disease
The Chinese Familial Alzheimer’s Network
Tau Positron Emission Tomography (PET) Longitudinal Substudy Associated With: Study of Crenezumab Versus Placebo in Preclinical Presenilin1 (PSEN1) E280A Mutation Carriers in the Treatment of Autosomal-Dominant Alzheimer’s Disease